Jan 18, 2017 at 10:50 | Source: Reuters
Twenty-two companies, including Pfizer, Merck, Novartis, Roche, Sanofi and GlaxoSmithKline, will contribute funds and expertise to the project, which is backed by the World Bank.
Jan 12, 2017 at 08:21 | Source:
Bengaluru-based biopharmaceutical firm Biocon on Wednesday said US drug regulator has accepted its partners Mylans biologics license application (BLA) for the proposed biosimilar of breast cancer drug Trastuzumab through the 351(k) pathway.
Dec 27, 2016 at 09:59 | Source:
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the USFDA for Tretinoin Capsules, 10 mg, the generic version of Vesanoid Capsules, 10 mg, of Hoffmann La Roche, Inc.
Dec 13, 2016 at 13:12 | Source:
Shilpa Medicare has received an approval from the United States Food & Drug Administration (USFDA) (the Office of Bioequivalence) for Capecitabine Tablets USP, 150 mg and 500 mg to be bioequivalent and therapeutically equivalent to the reference listed drug product (RLD), Xeloda Tablets, 150 mg and 500 mg of Hoffmann-La Roche, Inc.
Jun 04, 2016 at 15:30 | Source: PTI
Global pharma major Mylan Inc, and Biocon have confirmed the efficacy and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, incomparison to Roche's branded Herceptin used for treatment of cancer
Apr 26, 2016 at 22:08 | Source: PTI
The Delhi High Court has allowed pharma firms, Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd, to continue with manufacture and marketing of their breast cancer drug under their brand names 'CANMAb' and 'HERTRAZ'.
Apr 26, 2016 at 20:00 | Source: PTI
Biotechnology firm Biocon today said its product portfolio will not be affected by an order of the Delhi High Court that prevented the company from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
Mar 08, 2016 at 15:02 | Source: Betterinteriors
Roche Bobois launches Nouveaux Classiques collection
Jan 28, 2016 at 16:53 | Source: Betterinteriors
Roche Bobois store in Bangalore
Jan 22, 2016 at 18:45 | Source: Reuters
India's federal drugs controller issued an alert on Thursday, asking states to ensure Swiss drugmaker Roche's cancer treatment Avastin was not administered to treat eyes, after its usage hampered vision in 15 patients.
Messages on Roche »


New Member



i can`t believe how people are not able to understand what biocon is !! biocon is a world class biopharma firm, that has world class talent pool of scientists!! its trastuzumab biosimilar is showing much better results than herceptin which generates 40,000 crores alone in revenue for roche!! it

10.07 AM Jan 5th


New Member

0 Follower


The approved product is a generic version of Vesanoid capsules, 10 mg, of Hoffmann La Roche, Inc. (which is no longer being marketed in the US), the company added.

5.16 PM Dec 28th 2016

BSE/NSE Announcer

Platinum Member



to the reference listed drug product (RLD), Xeloda Tablets, 150 mg and 500 mg of Hoffmann-La Roche, Inc.

1.30 PM Dec 13th 2016

BSE/NSE Announcer

Platinum Member



and 500 mg of Hoffmann-La Roche, Inc.

1.12 PM Dec 13th 2016

high speed

New Member


Siti Cable  

siti cabel is going to roch....👍

2.42 PM Dec 12th 2016


Platinum Member



gone from having zero approved biosimilars to three, and it seems we are only at the beginning for this burgeoning industry, with key patents for such biologic blockbusters as AbbVie’s Humira and Roche’s Herceptin set to expire.

10.55 PM Sep 14th 2016


Platinum Member



Authorization Application filed by Mylan N.V. (MYL 2.9%) seeking approval of a biosimilar to Roche`s (OTCQX:RHHBY) Herceptin (trastuzumab). Mylan co-developed the product candidate with Indian biopharma firm Biocon (OTC:BCNQY).

9.18 PM Aug 25th 2016


Gold Member


Aurobindo Pharm  

? Haven`t heard more about it once Abott acquired it. They used to import Roche`s drugs and market it in India. Glenmark I again forgot completely, really like it and very good meds. Same I can say about Ranbaxy but after it was acquired dunno whats happening.

2.06 PM Feb 9th 2013


Platinum Member



my bajaj hindustan cochin minerals also roched ha ha ha.

10.59 PM Dec 7th 2012


Silver Member


Natco Pharma  

buy buy natco pharma target 445 target India spikes Roche Hepatitis patent in fresh blow for Big Pharma Mumbai/London, Nov 3, 2012, Reuters The Patents Appeal Board of India has revoked a patent granted six years ago on Roche’s Hepatitis C drug Pegasys. The Intellectual Property Appellate Board

10.50 AM Nov 8th 2012

News across the web »
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.